These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23712232)

  • 1. Effectiveness of haemodiafiltration with ultrafiltrate regeneration in renal failure due to multiple myeloma.
    Pendón-Ruiz de Mier MV; Ojeda-López R; Alvarez de Lara-Sánchez MA; Martín-Malo A; Aljama-García P
    Nefrologia; 2013; 33(3):426-8. PubMed ID: 23712232
    [No Abstract]   [Full Text] [Related]  

  • 2. [Renal failure].
    Arai T; Matsuzaki K
    Nihon Rinsho; 1995 Mar; 53(3):703-9. PubMed ID: 7699909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citrate Extended High Cut-Off Hemodiafiltration for Renal Recovery in Patients With Multiple Myeloma.
    Marn Pernat A; Medved B; Gubenšek J; Premru V; Knap B; Buturovic-Ponikvar J; Ponikvar R
    Ther Apher Dial; 2016 Jun; 20(3):251-5. PubMed ID: 27312910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hemodialysis on profound memory deficits in renal insufficiency due to multiple myeloma: a case study.
    Plagge JM; Clay JE; Redwine RL; LePage JP
    Appl Neuropsychol; 2009; 16(1):76-82. PubMed ID: 19205951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodiafiltration with ultrafiltrate regeneration in the removal of free light chains in multiple myeloma and acute kidney injury.
    Li Cavoli G; Passanante S; Schillaci O; Servillo F; Zagarrigo C; Li Cavoli TV; Palmeri M; Palma B; Rotolo U
    Nefrologia (Engl Ed); 2018; 38(3):337-338. PubMed ID: 28757277
    [No Abstract]   [Full Text] [Related]  

  • 6. Continuous ambulatory peritoneal dialysis in patients with renal failure due to multiple myeloma.
    Ahmad M
    Int Urol Nephrol; 2007; 39(2):629-33. PubMed ID: 17221282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenesis, prevention and treatment of multiple myeloma with peripheral neuritis and renal impairment].
    Li J
    Zhonghua Xue Ye Xue Za Zhi; 2013 Apr; 34(4):367-9. PubMed ID: 23668216
    [No Abstract]   [Full Text] [Related]  

  • 8. Complications of multiple myeloma.
    Bladé J; Rosiñol L
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1231-46, xi. PubMed ID: 17996596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal impairment in multiple myeloma: time is of the essence.
    Hutchison CA; Bridoux F
    J Clin Oncol; 2011 Apr; 29(11):e312-3; author reply e314. PubMed ID: 21343553
    [No Abstract]   [Full Text] [Related]  

  • 10. [Multiple myeloma nephropathy as a cause of renal failure--diagnostic difficulties and prospects for treatment].
    Polak G; Tomczak-Watras W; Nartowicz E
    Pol Arch Med Wewn; 1998 Sep; 100(3):257-61. PubMed ID: 10335031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib and dexamethasone in previously untreated multiple myeloma associated with renal failure and reversal of renal failure.
    Malani AK; Gupta V; Rangineni R
    Acta Haematol; 2006; 116(4):255-8. PubMed ID: 17119326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing myeloma of the kidney.
    Gertz MA
    Leuk Lymphoma; 2007 Feb; 48(2):221-2. PubMed ID: 17325878
    [No Abstract]   [Full Text] [Related]  

  • 13. A population-based study of the impact of dialysis on mortality in multiple myeloma.
    Evison F; Sangha J; Yadav P; Aung YS; Sharif A; Pinney JA; Drayson MT; Cook M; Cockwell P
    Br J Haematol; 2018 Feb; 180(4):588-591. PubMed ID: 27766629
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of multiple myeloma patients presenting with renal failure in a university hospital in the year 2010.
    Suyanı E; Sucak GT; Erten Y; Cakar MK; Ulusal G; Yağcı M; Haznedar R
    Ren Fail; 2012; 34(2):257-62. PubMed ID: 22260636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of daratumumab in dialysis-dependent renal failure secondary to multiple myeloma.
    Rocchi S; Tacchetti P; Pantani L; Mancuso K; Zannetti B; Cavo M; Zamagni E
    Haematologica; 2018 Jun; 103(6):e277-e278. PubMed ID: 29622654
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple myeloma. Part II: Treatment.
    Varet B; Choukroun G; Grünfeld JP
    Nephron; 1995; 70(1):18-20. PubMed ID: 7542366
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal disease in older people.
    Bevan M
    Nurs Older People; 2001 Sep; 13(6):21-5; quiz 26. PubMed ID: 12008549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal impairment at presentation in multiple myeloma continues to be associated with poor survival.
    Laing AA; Geddes C; Soutar R
    Br J Haematol; 2015 Jun; 169(6):901-2. PubMed ID: 25522297
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnosis and treatment in complication of multiple myeloma].
    Hou J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 38(5):437-8. PubMed ID: 19830853
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of the introduction of bortezomib on dialysis independence in multiple myeloma patients with renal impairment: a nationwide Dutch population-based study.
    Oortgiesen BE; Azad R; Hemmelder MH; Kibbelaar RE; Veeger NJGM; de Vries JC; van Roon EN; Hoogendoorn M
    Haematologica; 2018 Jul; 103(7):e311-e314. PubMed ID: 29545339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.